Arthrex’s TightRope implant has pediatric-specific instrumentation and is now the only ACL fixation device cleared for young patients, according to a news release.
Frank Cordasco, MD, and Daniel Green, MD, of New York City-based Hospital for Special Surgery helped develop the instruments for pediatric use.
“The expansion of Arthrex’s knee ligament portfolio to include pediatric- and young-adolescent-specific instrumentation and implants, along with the new indications cleared by the FDA, represents a substantial improvement on existing treatment options in this high-risk population of athletes,” Dr. Cordasco said in the release.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
